RVRC · Revium Rx.
$1.43
At close · Aug 21
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$86.84M
Shares
60.73M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Inna Martin | President | Resigned | 2026-06-22 |
| Inna Martin | Chief Operating Officer | Resigned | 2026-06-22 |
| Inna Martin | member of the Board of Directors | Resigned | 2026-06-22 |